| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K04800985 |
| PharmacoGx | BRD-K04800985 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TMEM164 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | FGF14 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | PREB | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | REEP1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | MBD3L5 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | SLC27A6 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | VEGFD | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | SLC52A2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | TAGAP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | EAPP | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
